Mario Roselli
0000-0002-2431-6689
70 papers found
Refreshing results…
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
Irinotecan or Oxaliplatin: Which is the First Move for the Mate?
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?
Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients:
Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass:
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges
Are there alternative ways to quantify the real benefit of novel agents in oncology? – the ‘death pace’
Impact ofVEGFgene polymorphisms in elderly cancer patients: clinical outcome and toxicity
Missing publications? Search for publications with a matching author name.